Pérez-Vizcaíno F, Villamor E, Moro M, Tamargo J
Department of Pharmacology, School of Medicine, Universidad Complutense, Madrid, Spain.
Eur J Pharmacol. 1996 Oct 24;314(1-2):91-8. doi: 10.1016/s0014-2999(96)00548-1.
The ability of several vasodilators to inhibit the responses to noradrenaline and U46619 (a thromboxane A2 analog) in isolated pulmonary and mesenteric arteries of neonatal piglets was compared. In pulmonary arteries, acetylcholine produced endothelium-dependent relaxations (pIC50 = about 6.8) while, in mesenteric arteries, a relaxant (< or = 10(-7) M) or a contractile response (> or = 10(-6) M) was observed. Sodium nitroprusside produced relaxant effects in pulmonary and mesenteric arteries contracted by noradrenaline (pIC50 = 6.6 and 6.0, respectively) and U46619 (pIC50 = 5.4 and 6.7, respectively). ATP induced an endothelium-independent relaxation in pulmonary arteries (pIC50 = about 4) but in mesenteric arteries it produced weak relaxant effects. In resting mesenteric arteries, ATP induced a concentration-dependent contraction which was not observed in pulmonary arteries. Prostaglandin E1 induced a contractile effect whereas, at higher concentrations, a relaxant response was observed. The alpha-adrenoceptor antagonist tolazoline had no effect on arteries contracted by U46619 but relaxed arteries contracted by noradrenaline being slightly more potent in mesenteric than in pulmonary arteries (pIC50 = 5.1 and 4.8, respectively). Nifedipine (> 10(-7) M) relaxed both arteries, mesenteric being more sensitive than pulmonary arteries and noradrenaline more sensitive than U46619-induced contractions. In conclusion, differences in the relaxant effects for all vasodilators were found depending on the artery, the vasoconstrictor used or both. However, ATP was the only drug which, regardless of the concentration or vasoconstrictor used, produced greater relaxant effects in pulmonary than in mesenteric arteries.
比较了几种血管舒张剂对新生仔猪离体肺和肠系膜动脉中去甲肾上腺素和U46619(一种血栓素A2类似物)反应的抑制能力。在肺动脉中,乙酰胆碱产生内皮依赖性舒张(pIC50约为6.8),而在肠系膜动脉中,观察到舒张反应(≤10⁻⁷ M)或收缩反应(≥10⁻⁶ M)。硝普钠对去甲肾上腺素(pIC50分别为6.6和6.0)和U46619(pIC50分别为5.4和6.7)收缩的肺和肠系膜动脉产生舒张作用。ATP在肺动脉中诱导非内皮依赖性舒张(pIC50约为4),但在肠系膜动脉中产生微弱的舒张作用。在静息的肠系膜动脉中,ATP诱导浓度依赖性收缩,而在肺动脉中未观察到。前列腺素E1诱导收缩作用,而在较高浓度时,观察到舒张反应。α-肾上腺素能受体拮抗剂妥拉唑啉对U46619收缩的动脉无作用,但对去甲肾上腺素收缩的动脉有舒张作用,在肠系膜动脉中的效力略高于肺动脉(pIC50分别为5.1和4.8)。硝苯地平(>10⁻⁷ M)使两种动脉舒张,肠系膜动脉比肺动脉更敏感,去甲肾上腺素诱导的收缩比U46619诱导的收缩更敏感。总之,发现所有血管舒张剂的舒张作用因动脉、所用血管收缩剂或两者而异。然而,ATP是唯一一种无论浓度或所用血管收缩剂如何,在肺动脉中产生的舒张作用都大于肠系膜动脉的药物。